摘要
非酒精性脂肪肝(NAFLD)不仅由于其患病率上升,更因为其缺乏可持续的治疗方案而成为是巨大的难题。肠道菌群被认为参与其发生和发展过程,因此,他们的控制作用被当作治疗目标研究。本文综述了肠道菌群对NAFLD发病机制的参与情况。此外,我们总结了旨在治疗NAFLD患者肠道微生态失调的最新的动物和人体实验研究结果。最后,我们综述了在治疗NAFLD时控制短链脂肪酸和胆汁酸信号的疗效的证据。
关键词: 胆汁酸,菌群失调,脂肪肝,肠道菌群,NAFLD,NASH。
图形摘要
Current Drug Targets
Title:Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease
Volume: 16 Issue: 12
Author(s): Marialena Mouzaki and Robert Bandsma
Affiliation:
关键词: 胆汁酸,菌群失调,脂肪肝,肠道菌群,NAFLD,NASH。
摘要: Non-alcoholic fatty liver disease (NAFLD) is a challenge not only due to its rising prevalence but also, and perhaps more importantly, due to the lack of sustainable treatment options. Intestinal microbiota are thought to participate in the development and progression of NAFLD and their manipulation is, hence, being investigated as a treatment aim. This review summarizes the involvement of intestinal microbiota in the pathogenesis on NAFLD. In addition, we synthesize the results of the most recent animal and human studies aimed at treating dysbiosis seen in patients with NAFLD. Lastly, we review the evidence regarding the efficacy of manipulating short chain fatty acid and bile acid signaling in the treatment of NAFLD.
Export Options
About this article
Cite this article as:
Marialena Mouzaki and Robert Bandsma , Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease, Current Drug Targets 2015; 16 (12) . https://dx.doi.org/10.2174/1389450116666150416120351
DOI https://dx.doi.org/10.2174/1389450116666150416120351 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pills of Emergency Medicine: Deal or Not Deal?
Reviews on Recent Clinical Trials New Molecular Targets in the Treatment of NSCLC
Current Pharmaceutical Design Pleiotropic Effects of PPARγ Agonist on Hemostatic Activation in Type 2 Diabetes Mellitus
Current Vascular Pharmacology Influence of Statin Use on Endothelial Function: From Bench to Clinics
Current Pharmaceutical Design Diabetes and Parkinson’s Disease: Debating the Link Through Ca2+/cAMP Signalling
Current Diabetes Reviews Family C 7TM Receptor Dimerization and Activation
Endocrine, Metabolic & Immune Disorders - Drug Targets Towards Better Care for Preterm Infants in Bamako, Mali
Current Women`s Health Reviews NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive β-Cell Dysfunction and Metabolic Syndrome
Current Drug Targets Combating Malaria with Plant Molecules: A Brief Update
Current Medicinal Chemistry Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Current Genomics Editorial [Hot Topic:Role of Food and Nutritional Factors in Metabolic Syndrome X,Cancer and Cardiovascular Diseases (Guest Editor: Undurti N. Das)]
Current Nutrition & Food Science Activation of the Innate Immune System in Atherosclerotic Disease
Current Pharmaceutical Design The Effect of <i>Myrtus communis</i> Aqueous Extract-Containing Gel on Wound Healing in Streptozotocin-Induced Diabetic Rats
Current Drug Discovery Technologies A New Approach for Skin-Derived Precursors to Ameliorate Skin Photodamage Through Activation of Nrf2 Signaling Pathway
Current Signal Transduction Therapy Olive Oil and Haemostasis: Platelet Function, Thrombogenesis and Fibrinolysis
Current Pharmaceutical Design A Review on Experimental Methods for Diabetes Induction and Therapeutic Efficacy of Anti-diabetic Drug Loaded Nanoformulation
Current Drug Therapy Molecular Mechanisms Involved in the Aging of the T-cell Immune Response
Current Genomics A Pre-Post Study of Vitamin D Supplement Effects on Urinary Megalin: The Emerging Predictive Role of Megalin in Diabetic Nephropathy Progression
Endocrine, Metabolic & Immune Disorders - Drug Targets Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature
Current Diabetes Reviews Reactivity-Based Drug Discovery Using Vitamin B6-Derived Pharmacophores
Mini-Reviews in Medicinal Chemistry